| Trial ID: | L4728 |
| Source ID: | NCT00192803
|
| Associated Drug: |
Candesartan
|
| Title: |
Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
NIDDM
|
| Interventions: |
DRUG: candesartan
|
| Outcome Measures: |
Primary: ACE and ACE2 activities in monocytes |
|
| Sponsor/Collaborators: |
Sponsor: Rambam Health Care Campus
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: ECT
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2006-02-23
|
| Locations: |
Internal Ward "A", Rambam Medical Center, Haifa, Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT00192803
|
